《國(guó)際生物醫(yī)學(xué)研究》是一份經(jīng)過(guò)同行評(píng)審的開(kāi)放獲取期刊，發(fā)表原創(chuàng)研究文章、綜述文章和臨床研究，涵蓋生命科學(xué)和醫(yī)學(xué)的廣泛主題。該雜志分為55個(gè)主題領(lǐng)域。國(guó)際生物醫(yī)學(xué)研究中心(BioMed Research International)在Portico存檔，它為電子學(xué)術(shù)期刊以及LOCKSS計(jì)劃提供永久存檔。它運(yùn)行一個(gè)完全開(kāi)放的訪問(wèn)發(fā)布模型，允許對(duì)其發(fā)布的內(nèi)容進(jìn)行開(kāi)放的全局訪問(wèn)。這個(gè)模型是通過(guò)文章處理費(fèi)來(lái)支持的。有關(guān)一般文章處理費(fèi)的更多信息，請(qǐng)點(diǎn)擊這里。國(guó)際生物醫(yī)學(xué)研究組織被收錄在許多領(lǐng)先的文摘和索引數(shù)據(jù)庫(kù)中。點(diǎn)擊這里查看完整列表。國(guó)際生物醫(yī)學(xué)研究由Abdelali Haoudi教授于2001年創(chuàng)立，他在2001年至2008年間擔(dān)任該雜志的主編。根據(jù)Clarivate Analytics在2018年發(fā)布的2017年期刊引文報(bào)告，國(guó)際生物醫(yī)學(xué)研究的最新影響因素是2.583。根據(jù)Scopus發(fā)布的CiteScore 2017指標(biāo)，《華爾街日?qǐng)?bào)》最新的CiteScore指數(shù)為2.55。

BioMed Research International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies covering a wide range of subjects in life sciences and medicine. The journal is divided into 55 subject areas.BioMed Research International is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. For more information on Article Processing charges in general, click here.BioMed Research International is included in many leading abstracting and indexing databases. For a complete list, click here.BioMed Research International was founded in 2001 by Professor Abdelali Haoudi who served as the Editor-in-Chief of the journal between 2001 and 2008.The most recent Impact Factor for BioMed Research International is 2.583 according to the 2017 Journal Citation Reports released by Clarivate Analytics in 2018. The journal’s most recent CiteScore is 2.55 according to the CiteScore 2017 metrics released by Scopus.